Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $3.01 | N/A |
Market Cap | $74.13M | N/A |
Shares Outstanding | 24.62M | 8.77% |
Employees | 10.00 | N/A |
Shareholder Equity | 1.95B | 162.02% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.86 | N/A |
P/S Ratio | 11.40 | N/A |
P/B Ratio | 0.04 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0003 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $6.50M | N/A |
Earnings | $614.35K | N/A |
EPS | 3.52 | N/A |
Earnings Yield | 1.17 | N/A |
Gross Margin | 0.7533 | N/A |
Operating Margin | 0.175 | N/A |
Net income margin | 0.0945 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $18.21M | N/A |
Total Debt | $949.25K | N/A |
Cash on Hand | $14.72M | N/A |
Debt to Equity | 0.0025 | -68.43% |
Cash to Debt | $15.51 | 195.44% |
Current Ratio | $4.23 | 88.05% |